EMA warns against use of riociguat in PH-IIP type pulmonary hypertension

EMA warns against use of riociguat in PH-IIP type pulmonary hypertension

June 29 2016 Adempas (riociguat) should not be used in patients with symptomatic pulmonary...

2015-16 flu vaccine effectiveness assessed in PHE report

2015-16 flu vaccine effectiveness assessed in PHE report

June 27 2016 The 2015-16 influenza vaccine effectiveness has been calculated at 57.6% in children...

Only fluoxetene considered of value in childhood major depressive disorder

Only fluoxetene considered of value in childhood major depressive disorder

June 15 2016 The bulk of commonly used antidepressants appear to have little value in the acute...

Weigh up risk of initiating antiepileptic therapy after an initial seizure, suggests Cochrane

Weigh up risk of initiating antiepileptic therapy after an initial seizure, suggests Cochrane

May 11 2016 Initiating antiepileptic drug therapy in someone who has had a first unprovoked...

  • EMA warns against use of riociguat in PH-IIP type pulmonary hypertension

    EMA warns against use of riociguat in PH-IIP type pulmonary hypertension

    Wednesday, 29 June 2016 10:44
  • 2015-16 flu vaccine effectiveness assessed in PHE report

    2015-16 flu vaccine effectiveness assessed in PHE report

    Tuesday, 28 June 2016 13:29
  • Only fluoxetene considered of value in childhood major depressive disorder

    Only fluoxetene considered of value in childhood major depressive disorder

    Wednesday, 15 June 2016 10:50
  • Final results from FLAME study confirms superiority of Ultibro Breezhaler over Seretide Accuhaler for reducing COPD exacerbations

    Final results from FLAME study confirms superiority of Ultibro Breezhaler over Seretide Accuhaler...

    Tuesday, 17 May 2016 12:01
  • Weigh up risk of initiating antiepileptic therapy after an initial seizure, suggests Cochrane

    Weigh up risk of initiating antiepileptic therapy after an initial seizure, suggests Cochrane

    Wednesday, 11 May 2016 11:32

iDOnateDecember 7 2015

The British Heart Foundation (BHF) is calling for the deemed consent organ donor system introduced in Wales to be rolled out across the UK.

Wales introduced a ‘soft opt-out’ organ donor system on December 1. It means that “people aged 18 and over who have lived in Wales for more than 12 months and who die in Wales will be regarded as having consented to organ donation unless they have opted out,” said the Welsh Government.

“People who want to be an organ donor can register a decision to opt in or do nothing, which will mean they have no objection to being an organ donor. Those people who do not want to be organ donor can opt out at any time.”

The move is expected to increase the number of organ donors by 25%. BHF pointed out that organ donation rates are up to 40% lower in the UK compared with other countries in Europe that already use the opt-out system such as Spain and Croatia.

Simon Gillespie, BHF Chief Executive, commented: “Other European countries that already use an opt-out system have much higher donor rates than the UK. We believe introducing a soft opt-out system, accompanied by awareness raising, education and investment in infrastructure will help increase organ donation rates in the UK and save more lives.

“We campaigned strongly in Wales to introduce soft opt-out and now it’s time for the rest of the UK to follow their lead.”

The NHS organ donation register website is currently undergoing beta-testing.

Links:

Welsh Government announcement

BHF announcement

Organ donation register website

Clinical News

June 29 2016 New guidance for healthcare professionals to support pregnant women experiencing nausea and vomiting and hyperemesis gravidum have been published.
December 10 2015 A doctor may find themselves the subject of an investigation at any time in their career, from medical students to trainee doctors, GPs or consultants. Whether it’s an issue...